Effect of KRAS mutational status on disease behavior and treatment outcome in patients with metastatic colorectal cancer: intra-tumor heterogeneity and Mutational status

Faculty	Medicine	Year:	2019
Type of Publication:	ZU Hosted	Pages:
Authors:
Journal:	Journal of Gastrointestinal Oncology AME Publishing Company	Volume:

Keywords :	Effect , KRAS mutational status , disease behavior
Abstract:	-Nowadays, the outcomes of metastatic colorectal cancer (mCRC) have considerably improved. Genetic studies evaluating KRAS mutational status are important in the personalized therapy era to understand disease heterogeneity, disease behaviors, and treatment outcomes. -A major association between KRAS mutational status and both disease behavior and treatment outcomes was found in this study. Patients with KRAS mutation show advanced disease presentation, with lower PFS and overall survival.

Author Related Publications

Heba Fekry Abdel Majid Taha, "Prognostic and Clinic-Pathological Significances of SCF and COX-2 Expression in Inflammatory and Malignant Prostatic Lesions", springer, 2018 More
Tarek Ali Mohamed Elgohary, "Study of Minimal Residual Disease in Adults with B-Lineage Acute Lymphoblastic Leukemia by Flowcytometry. دراسة الحد الأدنى للمرض المتبقي عند البالغين الذين يعانون من سرطان الدم اللمفاوي الحاد - بي بواسطة جهاز التدفق الخلوي", Journal of Cancer Therapy, 2017, 8, 386-398, 2017 More
Ola Mohamed Ahmed Elfarargy, "Peripheral and Tissue Lymphocytes as Predictors of Pathological Response in Locally Advanced Rectal Cancer Post Neoadjuvant Chemoradiotherapy", scintific research publishing, 2017 More
Amarallah Abdelmoneim Mohamed Sayed, "Impact of vitamin D serum levels on clinicopathological features and outcome in advanced pancreatic carcinoma", Sciendo, 2019 More
Shereen Mostafa Saleh Elshorbagy, "The Prognostic Roles of PYCR2 and ZBTB18 Expression in Tissues of Colorectal Carcinoma and Non-Neoplastic Tissues: An Immunohistochemical Study", THIEME, 2022 More